COMMUNIQUÉS West-GlobeNewswire

MediPharm Labs Appoints Renowned Cannabis Researcher Dr. Landolt-Marticorena, MD, PhD, to its Science Advisory Committee
20/08/2019
TORONTO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction, [...]
Tonix Pharmaceuticals Expands Preclinical Pipeline with Triple Reuptake Inhibitor, TNX-1600, for the Treatment of PTSD
20/08/2019
NEW YORK, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today an exclusive agreement to in-license a [...]
Entera Bio Reports Second Quarter 2019 Financial Results and Provides Operating Update
20/08/2019
Phase 2 study for oral PTH in osteoporosis was initiated in June 2019; Data expected in 2020 Completed Part 2 of a Phase 2 PK/PD study in hypoparathyroidism patients. Results expected to be presented in Q3 2019. [...]
Avricore Health Corporate Update and Private Placement Extension
20/08/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) ("Avricore Health" or the " [...]
Medtronic Reports First Quarter Financial Results
20/08/2019
Revenue of $7.5 Billion Increased 1.5% Reported; Increased 3.5% Constant Currency GAAP Diluted EPS of $0.64; Non-GAAP Diluted EPS of $1.26 Company Raises FY20 EPS Guidance by 10 Cents DUBLIN, Aug. 20, 2019 (GLOBE [...]
Transactions in relation to share buyback program
20/08/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
Medcolcanna Signs Licensing and Profit-Sharing Agreement with Herbolea Biotech for Patent Pending Technology
20/08/2019
BOGOTÁ, Colombia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc . (TSX-V: MCCN) (“ Medcolcanna ” or the “ Company ”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce [...]
Parallax Health Sciences Reports Second Quarter 2019 Financial Results
20/08/2019
Company Reduces Net Loss by 40% Over Prior Year Six Months Period SANTA MONICA, Calif., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Parallax Health Sciences, Inc. (OTCQB: PRLX) (“Parallax”), an outcome-driven connected healthcare [...]
AB Science annonce le succès d'un placement privé
20/08/2019
AB SCIENCE REALISE AVEC SUCCES UN PLACEMENT PRIVE EUR 10,00 millions levés par un placement privé de 2.263.054 actions ordinaires nouvelles au prix de EUR 4,06 (assorties de bons de souscription d’actions donnant droit [...]
AgraFlora Organics Enters Into Exclusive Asian CBD Cosmetics Distribution Agreement; Achieves Immediate Access to China’s Projected US$15,000,000,000 CBD Marketplace
20/08/2019
VANCOUVER, British Columbia, Aug. 20, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]
Nexstim reports good initial results on the use of Smartfocus® technology in treatment of major depressive disorder
20/08/2019
Press Release, Helsinki, 20 August 2019 at 10.00 am (EET) Nexstim reports good initial results on the use of Smartfocus ® technology in treatment of major depressive disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim [...]
Coloplast: Announcement no. 8/2019 - Meet the Management Event 2019
20/08/2019
Announcement No. 8 /2019 20 August, 2019 Coloplast’s Meet the Management Event in London Coloplast is hosting a Meet the Management Event in London today at 10:30 local time. The purpose of the event is to provide [...]
Araris Biotech AG closes seed financing round of CHF 2.5 million
20/08/2019
Redalpine, Schroder Adveq and VI Partners participated in round Proceeds to support development of own antibody-drug-conjugates (ADCs) ZURICH, Switzerland, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Araris Biotech AG announced [...]
Nomination committee in Oasmia for the 2019 AGM
20/08/2019
In accordance with the decision at the Annual General Meeting of Oasmia Pharmaceutical AB on September 25, 2018, the two largest shareholders in terms of voting rights who have chosen to participate in the Nomination [...]
Immunicum AB (publ) Interim Report January – June 2019
20/08/2019
Press Release 20 August 2019 Immunicum AB (publ) Interim Report January – June 2019 Positive results from GIST study and MERECA data approaching SIGNIFICANT EVENTS DURING APRIL - JUNE Net sales for the period amounted [...]
NeuroSearch – Updated financial calendar for 2019
20/08/2019
Announcement 20 August 2019 NeuroSearch A/S (NEUR) hereby announces an updated company’s financial calendar for 2019. 21 August 2019 Interim report for H1 2019 (will be released after 5 p.m.) Allan Andersen CEO Contact [...]
Oxurion NV Reports Topline Month 3 Results of Phase 2a Study Evaluating THR-317 (anti-PLGF), in Combination with Ranibizumab, for DME
20/08/2019
Combination therapy did not show increase in BCVA in the overall population at Month 3. Certain improvement in mean BCVA at Month 3 observed with the combination therapy in 2 pre-specified subgroups: poor (or non) [...]
Basilea reports significantly increased cash-generating revenue, flat operating expenses and reduced net loss for half-year 2019
20/08/2019
Revenue from Cresemba ® and Zevtera ® increased by 91% to CHF 53 million Operating result improved by 35% Expansion of derazantinib clinical program into urothelial cancer with immunotherapy combination Positive phase 3 [...]
Eve & Co Announces Financial Results for the Three and Six Month Periods Ended June 30, 2019
20/08/2019
TORONTO, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce its interim financial results for the three and six month periods [...]

Pages